世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い
詳細検索
2025/04/03 10:27
148.83 円
162.56 円
196.84 円
医薬 市場調査レポート
- このリストでは医薬市場に関する調査レポートを新刊順に紹介しています。
例えば、薬学的薬物、生化学的薬物、バイオ薬物、抗感染性薬物といった分野の動向に関する調査レポート (技術動向、市場規模予測)を紹介しています。又、調剤薬、診断薬、公衆衛生用薬、治療を主目的としない薬物に関する調査レポートも紹介しています。
- 髄膜腫 (腫瘍学) - 開発段階の治療薬 2021年
- Meningioma (Oncology) - Drugs in Development, 2021
- 価格 US$ 2,000 ｜ Global Markets Direct ｜ ―
- Meningioma (Oncology) - Drugs in Development, 2021SummaryMeningioma (Oncology) - Drugs in Development, 2021 provides an overview of the Meningioma pipeline landscape.The report provides comprehensive information on the therapeutics under development for M…
- このレポートの詳細ページはこちら
- 腎細胞がん (腫瘍学) - 開発段階の治療薬 2021年
- Renal Cell Carcinoma (Oncology) - Drugs in Development, 2021
- 価格 US$ 2,500 ｜ Global Markets Direct ｜ ―
- Renal Cell Carcinoma (Oncology) - Drugs in Development, 2021SummaryRenal Cell Carcinoma (Oncology) - Drugs in Development, 2021 provides an overview of the Renal Cell Carcinoma pipeline landscape.The report provides comprehensive information on the therap…
- このレポートの詳細ページはこちら
- 心内膜炎 (循環器) - 開発段階の治療薬 2021年
- Endocarditis (Cardiovascular) - Drugs in Development, 2021
- 価格 US$ 2,000 ｜ Global Markets Direct ｜ ―
- Endocarditis (Cardiovascular) - Drugs in Development, 2021SummaryEndocarditis (Cardiovascular) - Drugs in Development, 2021 provides an overview of the Endocarditis pipeline landscape.The report provides comprehensive information on the therapeutics under…
- このレポートの詳細ページはこちら
- 心筋症 (循環器) - 開発段階の治療薬 2021年
- Cardiomyopathy (Cardiovascular) - Drugs in Development, 2021
- 価格 US$ 2,000 ｜ Global Markets Direct ｜ ―
- Cardiomyopathy (Cardiovascular) - Drugs in Development, 2021SummaryCardiomyopathy (Cardiovascular) - Drugs in Development, 2021 provides an overview of the Cardiomyopathy pipeline landscape.The report provides comprehensive information on the therapeutics…
- このレポートの詳細ページはこちら
- 食物アレルギー (免疫学) - 開発段階の治療薬 2021年
- Food Allergy (Immunology) - Drugs in Development, 2021
- 価格 US$ 2,000 ｜ Global Markets Direct ｜ ―
- Food Allergy (Immunology) - Drugs in Development, 2021SummaryFood Allergy (Immunology) - Drugs in Development, 2021 provides an overview of the Food Allergy pipeline landscape.The report provides comprehensive information on the therapeutics under develop…
- このレポートの詳細ページはこちら
- 食道胃接合部腺がん (腫瘍学) - 開発段階の治療薬 2021年
- Adenocarcinoma Of The Gastroesophageal Junction (Oncology) - Drugs in Development, 2021
- 価格 US$ 2,500 ｜ Global Markets Direct ｜ ―
- Adenocarcinoma Of The Gastroesophageal Junction (Oncology) - Drugs in Development, 2021SummaryAdenocarcinoma Of The Gastroesophageal Junction (Oncology) - Drugs in Development, 2021 provides an overview of the Adenocarcinoma Of The Gastroesophageal Juncti…
- このレポートの詳細ページはこちら
- 上皮性卵巣がん (腫瘍学) - 開発段階の治療薬 2021年
- Epithelial Ovarian Cancer (Oncology) - Drugs in Development, 2021
- 価格 US$ 2,500 ｜ Global Markets Direct ｜ ―
- Epithelial Ovarian Cancer (Oncology) - Drugs in Development, 2021SummaryEpithelial Ovarian Cancer (Oncology) - Drugs in Development, 2021 provides an overview of the Epithelial Ovarian Cancer pipeline landscape.The report provides comprehensive informatio…
- このレポートの詳細ページはこちら
- 上衣腫 (腫瘍学) - 開発段階の治療薬 2021年
- Ependymoma (Oncology) - Drugs in Development, 2021
- 価格 US$ 2,000 ｜ Global Markets Direct ｜ ―
- Ependymoma (Oncology) - Drugs in Development, 2021SummaryEpendymoma (Oncology) - Drugs in Development, 2021 provides an overview of the Ependymoma pipeline landscape.The report provides comprehensive information on the therapeutics under development for E…
- このレポートの詳細ページはこちら
- 子癇前症 (循環器) - 開発段階の治療薬 2021年
- Pre-Eclampsia (Cardiovascular) - Drugs in Development, 2021
- 価格 US$ 2,000 ｜ Global Markets Direct ｜ ―
- Pre-Eclampsia (Cardiovascular) - Drugs in Development, 2021SummaryPre-Eclampsia (Cardiovascular) - Drugs in Development, 2021 provides an overview of the Pre-Eclampsia pipeline landscape.The report provides comprehensive information on the therapeutics un…
- このレポートの詳細ページはこちら
- 再発性慢性リンパ球性白血病 (CLL) (腫瘍学) - 開発段階の治療薬 2021年
- Relapsed Chronic Lymphocytic Leukemia (CLL) (Oncology) - Drugs in Development, 2021
- 価格 US$ 2,000 ｜ Global Markets Direct ｜ ―
- Relapsed Chronic Lymphocytic Leukemia (CLL) (Oncology) - Drugs in Development, 2021SummaryRelapsed Chronic Lymphocytic Leukemia (CLL) (Oncology) - Drugs in Development, 2021 provides an overview of the Relapsed Chronic Lymphocytic Leukemia (CLL) pipeline …
- このレポートの詳細ページはこちら
- 再発性多形性膠芽腫 (GBM) (腫瘍学) - 開発段階の治療薬 2021年
- Recurrent Glioblastoma Multiforme (GBM) (Oncology) - Drugs in Development, 2021
- 価格 US$ 2,500 ｜ Global Markets Direct ｜ ―
- Recurrent Glioblastoma Multiforme (GBM) (Oncology) - Drugs in Development, 2021SummaryRecurrent Glioblastoma Multiforme (GBM) (Oncology) - Drugs in Development, 2021 provides an overview of the Recurrent Glioblastoma Multiforme (GBM) pipeline landscape.Th…
- このレポートの詳細ページはこちら
- 再発急性骨髄性白血病 (腫瘍学) - 開発段階の治療薬 2021年
- Relapsed Acute Myeloid Leukemia (Oncology) - Drugs in Development, 2021
- 価格 US$ 2,500 ｜ Global Markets Direct ｜ ―
- Relapsed Acute Myeloid Leukemia (Oncology) - Drugs in Development, 2021SummaryRelapsed Acute Myeloid Leukemia (Oncology) - Drugs in Development, 2021 provides an overview of the Relapsed Acute Myeloid Leukemia pipeline landscape.The report provides compre…
- このレポートの詳細ページはこちら
- 高悪性度神経膠腫 (腫瘍学) - 開発段階の治療薬 2021年
- High-Grade Glioma (Oncology) - Drugs in Development, 2021
- 価格 US$ 2,000 ｜ Global Markets Direct ｜ ―
- High-Grade Glioma (Oncology) - Drugs in Development, 2021SummaryHigh-Grade Glioma (Oncology) - Drugs in Development, 2021 provides an overview of the High-Grade Glioma pipeline landscape.The report provides comprehensive information on the therapeutics un…
- このレポートの詳細ページはこちら
- 高トリグリセリド血症 (循環器) - 開発段階の治療薬 2021年
- Hypertriglyceridemia (Cardiovascular) - Drugs in Development, 2021
- 価格 US$ 2,000 ｜ Global Markets Direct ｜ ―
- Hypertriglyceridemia (Cardiovascular) - Drugs in Development, 2021SummaryHypertriglyceridemia (Cardiovascular) - Drugs in Development, 2021 provides an overview of the Hypertriglyceridemia pipeline landscape.The report provides comprehensive information o…
- このレポートの詳細ページはこちら
- 甲状腺乳頭がん (腫瘍学) - 開発段階の治療薬 2021年
- Papillary Thyroid Cancer (Oncology) - Drugs in Development, 2021
- 価格 US$ 2,000 ｜ Global Markets Direct ｜ ―
- Papillary Thyroid Cancer (Oncology) - Drugs in Development, 2021SummaryPapillary Thyroid Cancer (Oncology) - Drugs in Development, 2021 provides an overview of the Papillary Thyroid Cancer pipeline landscape.The report provides comprehensive information o…
- このレポートの詳細ページはこちら
- 筋層非浸潤性膀胱がん (NMIBC) (表在性膀胱がん) (腫瘍学) - 開発段階の治療薬 2021年
- Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial Bladder Cancer) (Oncology) - Drugs in Development, 2021
- 価格 US$ 2,000 ｜ Global Markets Direct ｜ ―
- Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial Bladder Cancer) (Oncology) - Drugs in Development, 2021SummaryNon Muscle Invasive Bladder Cancer (NMIBC) (Superficial Bladder Cancer) (Oncology) - Drugs in Development, 2021 provides an overview of t…
- このレポートの詳細ページはこちら
- 筋層浸潤性膀胱がん (MIBC) (腫瘍学) - 開発段階の治療薬 2021年
- Muscle Invasive Bladder Cancer (MIBC) (Oncology) - Drugs in Development, 2021
- 価格 US$ 2,000 ｜ Global Markets Direct ｜ ―
- Muscle Invasive Bladder Cancer (MIBC) (Oncology) - Drugs in Development, 2021SummaryMuscle Invasive Bladder Cancer (MIBC) (Oncology) - Drugs in Development, 2021 provides an overview of the Muscle Invasive Bladder Cancer (MIBC) pipeline landscape.The repo…
- このレポートの詳細ページはこちら
- 胸腺がん (腫瘍学) - 開発段階の治療薬 2021年
- Thymic Carcinoma (Oncology) - Drugs in Development, 2021
- 価格 US$ 2,000 ｜ Global Markets Direct ｜ ―
- Thymic Carcinoma (Oncology) - Drugs in Development, 2021SummaryThymic Carcinoma (Oncology) - Drugs in Development, 2021 provides an overview of the Thymic Carcinoma pipeline landscape.The report provides comprehensive information on the therapeutics under…
- このレポートの詳細ページはこちら
- 急性肺障害 (呼吸器) - 開発段階の治療薬 2021年
- Acute Lung Injury (Respiratory) - Drugs in Development, 2021
- 価格 US$ 2,000 ｜ Global Markets Direct ｜ ―
- Acute Lung Injury (Respiratory) - Drugs in Development, 2021SummaryAcute Lung Injury (Respiratory) - Drugs in Development, 2021 provides an overview of the Acute Lung Injury pipeline landscape.The report provides comprehensive information on the therapeut…
- このレポートの詳細ページはこちら
- 急性心不全 (循環器) - 開発段階の治療薬 2021年
- Acute Heart Failure (Cardiovascular) - Drugs in Development, 2021
- 価格 US$ 2,000 ｜ Global Markets Direct ｜ ―
- Acute Heart Failure (Cardiovascular) - Drugs in Development, 2021SummaryAcute Heart Failure (Cardiovascular) - Drugs in Development, 2021 provides an overview of the Acute Heart Failure pipeline landscape.The report provides comprehensive information on t…
- このレポートの詳細ページはこちら
他産業の新着レポートを見る
カテゴリ別にレポートを見る